Open-End Hybrid Mutual Funds:
Target Date Mutual Funds & More

Recently Released!!!
Date Published: March 15, 2023
Summary PowerPoint Deck: 287 Slides

Reference PowerPoint Deck: 1,408 Slides

The purpose of this research is to provide readers with a comprehensive understanding of open-end hybrid mutual funds, a market which includes target date mutual funds. This research addresses the market's segements and future predictions. Other Tiburon research topics address open-end stock mutual funds, open-end bond mutual funds, & open-end money market mutual funds. And these four topics are summarized in Tiburon's coverage of open-end mutual funds.

This research starts with a review of open-end hybrid mutual funds' market growth and the leading fund sponsors of open-end hybrid mutual funds.

This research addresses open-end hybrid mutual funds' market segments, including:
  • Target Date Mutual Funds
  • Balanced Mutual Funds
And the research concludes with future predictions for open-end hybrid mutual funds, including:
  • Moderate Market Growth for Open-End Hybrid Mutual Funds
  • Fastest Growth for Target Date Mutual Funds
  • Continuing Dominance of Target Date Mutual Funds in Defined Contribution Plans

Member Access

Tiburon Members & individual research subscribers may click on any of the icons below to access any part of this research. The most widely utilized parts are the Key Findings (think factoids), Podcast Presentation, and Summary PowerPoint deck.

Table of Contents Summary
PowerPoint Deck
Key Findings Reference
PowerPoint Deck
Podcast Presentation Excel Data Sheet
Public Access

Please click on the Table of Contents icon below to see more details of this research.

Table of Contents

Media Access

Members of the media who would like further access to the components of this research may click on the icon below or send an email to Sarah Sage.

Media Access

Tiburon Research Subscriptions

Subscribe

If you are having difficulties subscribing to Tiburon research online please contact Sarah Sage at
SSage@TiburonAdvisors.Com or 415-789-2540.